PL3322438T3 - Inhibitory il-8 do zastosowania w leczeniu pewnych zaburzeń urologicznych - Google Patents

Inhibitory il-8 do zastosowania w leczeniu pewnych zaburzeń urologicznych

Info

Publication number
PL3322438T3
PL3322438T3 PL16738165T PL16738165T PL3322438T3 PL 3322438 T3 PL3322438 T3 PL 3322438T3 PL 16738165 T PL16738165 T PL 16738165T PL 16738165 T PL16738165 T PL 16738165T PL 3322438 T3 PL3322438 T3 PL 3322438T3
Authority
PL
Poland
Prior art keywords
inhibitors
treatment
urological disorders
certain urological
certain
Prior art date
Application number
PL16738165T
Other languages
English (en)
Inventor
Marcello Allegretti
Andrea Aramini
Maria Candida Cesta
Gianluca Bianchini
Laura Brandolini
Patrizia Angelico
Original Assignee
Dompé Farmaceutici S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dompé Farmaceutici S.P.A. filed Critical Dompé Farmaceutici S.P.A.
Publication of PL3322438T3 publication Critical patent/PL3322438T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41681,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • A61K31/4211,3-Oxazoles, e.g. pemoline, trimethadione
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/4261,3-Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/664Amides of phosphorus acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL16738165T 2015-07-14 2016-07-12 Inhibitory il-8 do zastosowania w leczeniu pewnych zaburzeń urologicznych PL3322438T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15176726.6A EP3117835A1 (en) 2015-07-14 2015-07-14 Il-8 inhibitors for use in the treatment of certain urological disorders
EP16738165.6A EP3322438B1 (en) 2015-07-14 2016-07-12 Il-8 inhibitors for use in the treatment of certain urological disorders
PCT/EP2016/066511 WO2017009323A1 (en) 2015-07-14 2016-07-12 Il-8 inhibitors for use in the treatment of certain urological disorders

Publications (1)

Publication Number Publication Date
PL3322438T3 true PL3322438T3 (pl) 2022-01-03

Family

ID=53757997

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16738165T PL3322438T3 (pl) 2015-07-14 2016-07-12 Inhibitory il-8 do zastosowania w leczeniu pewnych zaburzeń urologicznych

Country Status (25)

Country Link
US (2) US12150933B2 (pl)
EP (2) EP3117835A1 (pl)
JP (1) JP6937738B2 (pl)
KR (1) KR102622924B1 (pl)
CN (1) CN107921105B (pl)
AU (1) AU2016292902B2 (pl)
CA (1) CA2991810C (pl)
CY (1) CY1125437T1 (pl)
DK (1) DK3322438T3 (pl)
EA (2) EA202190242A1 (pl)
ES (1) ES2894077T3 (pl)
HR (1) HRP20211574T1 (pl)
HU (1) HUE056439T2 (pl)
IL (1) IL256413B (pl)
LT (1) LT3322438T (pl)
MA (1) MA42437A (pl)
MD (1) MD3322438T2 (pl)
MX (1) MX2018000539A (pl)
PL (1) PL3322438T3 (pl)
PT (1) PT3322438T (pl)
RS (1) RS62413B1 (pl)
SI (1) SI3322438T1 (pl)
SM (1) SMT202100582T1 (pl)
WO (1) WO2017009323A1 (pl)
ZA (1) ZA201708608B (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3342407A1 (en) * 2017-01-03 2018-07-04 Dompé farmaceutici S.p.A. Il-8 inihibitors for use in the treatment of some urological disorders
EP3409277A1 (en) 2017-05-30 2018-12-05 Dompé farmaceutici s.p.a. Il-8 inhibitors for use in the treatment and/or prevention of bacterial secondary infections
CN114712377B (zh) * 2022-04-26 2023-08-15 江苏师范大学 断血流皂苷a在制造药物中的用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11503110A (ja) * 1995-02-17 1999-03-23 スミスクライン・ビーチャム・コーポレイション Il−8受容体拮抗剤
TW200530231A (en) 2003-12-22 2005-09-16 Schering Corp Isothiazole dioxides as CXC-and CC-chemokine receptor ligands
PL1776336T3 (pl) * 2004-03-23 2010-06-30 Dompe Farm Spa Pochodne kwasu 2-fenylopropionowego i zawierające je kompozycje farmaceutyczne
EP2166006A1 (en) 2008-09-18 2010-03-24 Dompe' S.P.A. 2-aryl-propionic acids and derivatives and pharmaceutical compositions containing them
WO2010078403A2 (en) 2008-12-30 2010-07-08 Lipella Pharmaceuticals Inc. Methods and compositions for diagnosing urological disorders
KR101458947B1 (ko) * 2013-03-05 2014-11-12 국립암센터 인터루킨-8 앱타머 및 이의 용도

Also Published As

Publication number Publication date
CN107921105A (zh) 2018-04-17
EA202190242A1 (ru) 2021-11-30
SMT202100582T1 (it) 2021-11-12
CA2991810C (en) 2025-05-27
JP2018520184A (ja) 2018-07-26
MA42437A (fr) 2021-06-02
LT3322438T (lt) 2021-10-25
CA2991810A1 (en) 2017-01-19
US12150933B2 (en) 2024-11-26
CY1125437T1 (el) 2023-03-24
CN107921105B (zh) 2022-08-02
ZA201708608B (en) 2019-05-29
DK3322438T3 (da) 2021-10-18
RS62413B1 (sr) 2021-10-29
EP3322438B1 (en) 2021-09-08
HRP20211574T1 (hr) 2022-02-04
SI3322438T1 (sl) 2021-11-30
PT3322438T (pt) 2021-10-01
US20180200231A1 (en) 2018-07-19
NZ739077A (en) 2023-12-22
BR112018000676A2 (pt) 2018-09-18
ES2894077T3 (es) 2022-02-11
MX2018000539A (es) 2018-09-06
IL256413B (en) 2021-04-29
MD3322438T2 (ro) 2022-01-31
WO2017009323A1 (en) 2017-01-19
EP3117835A1 (en) 2017-01-18
US20250032461A1 (en) 2025-01-30
AU2016292902A1 (en) 2018-01-18
EP3322438A1 (en) 2018-05-23
JP6937738B2 (ja) 2021-09-22
EA201890312A1 (ru) 2018-08-31
HUE056439T2 (hu) 2022-02-28
AU2016292902B2 (en) 2021-06-03
KR20180030075A (ko) 2018-03-21
KR102622924B1 (ko) 2024-01-09
IL256413A (en) 2018-02-28

Similar Documents

Publication Publication Date Title
IL285151A (en) Methods of treating fgf21-associated disorders
HUE064141T2 (hu) Azolopirimidin rákkal összefüggõ rendellenességek kezelésére
PL3472153T3 (pl) Pirymidyn-2-yloamino-1h-pirazole jako inhibitory lrrk2 do zastosowania w leczeniu zaburzeń neurodegeneracyjnych
IL253945A0 (en) kdm1a inhibitors to treat the disease
IL256056A (en) Ezh2 inhibitors for treating lymphoma
IL256209A (en) Novel cannabinoid combination therapies for multiple myeloma (mm)
PL3157534T3 (pl) Inhibitory acetylocholinesteraz w leczeniu stanów dermatologicznych
DK3347030T3 (da) Brug af pasteuriseret akkermansia til behandling af stofskiftesygdomme
LT3261640T (lt) 5ht agonistai epilepsijos sutrikimų gydymui
IL269174A (en) Methods for treating complement-mediated diseases and disorders
DK3277815T3 (da) Oligonukleotidforbindelser til behandling af præeklampsi og andre angiogene lidelser
DK3212233T3 (da) Kombinationsterapi til behandling af sygdom
DK3240612T3 (da) Fremgangsmåder til behandling af nethindesygdomme
HUE056287T2 (hu) Pancreatitis kezelése
DK3485890T3 (da) Sglt2-hæmmere til behandling af stofskifteforstyrrelser hos hundedyr
IL256206A (en) Mct4 inhibitors for treating disease
DK3164394T3 (da) Gls1-inhibitorer til behandling af sygdomme
DK3430143T3 (da) Inhibitorer af SRSF1 til behandlingen af neurodegenerative sygdomme
LT3534885T (lt) Farneziltransferazės inhibitoriai, skirti naudoti vėžio gydymui
LT3402474T (lt) Il-8 inhibitoriai, skirti panaudoti chemoterapijos sukeltos periferinės neuropatijos gydymui
IL280227A (en) Arimoclomol for treating glucocerebrosidase associated disorders
SMT202100177T1 (it) Trattamento di disturbi neutologici
HUE063820T2 (hu) Módszerek kardiovaszkuláris betegségek kezelésére
DK3096775T5 (da) SOCS-mimetika til behandling af sygdomme
PL3322438T3 (pl) Inhibitory il-8 do zastosowania w leczeniu pewnych zaburzeń urologicznych